// App-Quantinova.ai

875 : Acquisition of chemoresistance in tumor cells requires crosstalk between dying and remnant live tumor cells via HMGB1

Researchers

Presenter

  • Junmin Zhou

Principal Investigators

  • Xianghong Chen

  • Danielle L. Gilvary

  • Melba Marie Tejera

  • Erika A. Eksioglu

  • Thu Le Trinh

  • Sheng Wei

  • Julie Djeu

Medical Centers

  • Moffitt Cancer Center, Tampa, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

  • Urology

Disease

  • Prostate cancer

  • Solid malignancies

  • Twin-reversed arterial perfusion

Biomarkers

  • Clusterin

  • High Mobility Group Box 1

Drug/Treatment

  • Carboplatin

  • Gemcitabine

  • Doxorubicin

  • Docetaxel

  • Etoposide

  • Etoposide phosphate

  • Cisplatin

  • Paclitaxel

  • ara-c

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved